TSHA
Taysha Gene Therapies, Inc.Company with tickers: TSHA
Market Cap
$1.99B
Shares Outstanding
287,361,020
CIK
1806310
CUSIP
877619106
13F Activity (30d)
2 filings
1 filers
Website
Visit website
Press releases and events scraped from the company's investor relations website. News and event listings link back to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-06-22 | TSHA-102 Rett Syndrome Program Update Conference Call | Conference |
| 2026-05-06 | Taysha Gene Therapies First Quarter 2026 Financial Results Conference Call | Conference |
| 2026-03-19 | Taysha Gene Therapies Full-Year 2025 Financial Results Conference Call | Conference |
| 2025-11-04 | Taysha Gene Therapies Third Quarter 2025 Financial Results Conference Call | Conference |
| 2025-08-12 | Taysha Gene Therapies Second Quarter 2025 Financial Results Conference Call | Conference |